# ZITUVIO

NDC: 70771-1771
Generic name: Sitagliptin
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20231130

FDA application: NDA211566

## Active ingredients

- SITAGLIPTIN: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1771"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1771
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2da9d77-154b-48f7-8793-3f4a24dfafc6
